Thalidomide and immunomodulatory derivatives augment natural killer cell cytotoxicity in multiple myelomaFaith E. Davies, Kenneth C. Anderson, Boris K. Lin et al.|Blood|2001Cited by 905
Activin A promotes multiple myeloma-induced osteolysis and is a promising target for myeloma bone diseaseSonia Vallet, Noopur Raje, Siddhartha Mukherjee et al.|Proceedings of the National Academy of Sciences|2010Cited by 235
Structure-Guided Development of a Potent and Selective Non-covalent Active-Site Inhibitor of USP7Ilaria Lamberto, Sara J. Buhrlage, Xiaoxi Liu et al.|Cell chemical biology|2017Cited by 188